High-purity peptide active ingredient with molecular structures

Hybio Product Center

Science engineeredfor therapeutic impact.

An integrated peptide platform spanning finished dosage forms, high-purity active ingredients, and end-to-end CRDMO partnership.

Peptide therapeutics · Global supply

Product Categories

Three platforms. One therapeutic focus.

Select a platform to explore how Hybio connects specialized science with global development and supply.

01 / FDF

Precision formulations

Finished Dosage Form

A multi-dosage-form technology platform translating peptide science into reliable, globally accessible therapies.

Explore platform

01 / Finished Dosage Form

Precision formulations for peptide therapeutics.

A multi-dosage-form technology platform translating peptide science into reliable, globally accessible therapies.

Explore FDF

Peptide FDF approvals

90+

Global FDF markets

Multi

Dosage-form platform

Technology

01Multi-dosage formulation development
02Impurity and structural characterization
03Commercial-scale sterile manufacturing

Applications

01Metabolic and endocrine care
02Reproductive health
03Rare and specialty therapeutics

Advantages

01Multiple delivery formats
02International quality systems
03Global commercial supply

02 / Peptide API

High-purity peptide APIs, built to scale.

High-purity peptide active ingredients powered by proprietary synthesis, purification, and scale-up technologies.

Explore API

20+

International API markets

30+

Amino-acid capability

mg→T

Development scale

Technology

01Solid and liquid-phase synthesis
02High-efficiency purification
03Sequence-specific impurity control

Applications

01GLP-1 and metabolic therapies
02Oncology and endocrine care
03Complex and long-chain peptides

Advantages

01Process innovation
02Controlled impurity profiles
03Scalable production

03 / CRDMO

One partner from discovery to commercial supply.

End-to-end research, development, clinical, manufacturing, and commercialization support for complex peptide programs.

Explore CRDMO

20+

Years of peptide expertise

25d

Fastest API turnaround

IND→NDA

Registration support

Technology

01AI-assisted molecular design
02Analytical and quality studies
03Global regulatory support

Applications

01Innovative peptide programs
02Generic drug development
03Lifecycle and market expansion

Advantages

01Discovery to IND
02Clinical supply
03Commercial manufacturing

Integrated Peptide Platform

One connected path from discovery to patients.

Scientific, development, manufacturing, and commercial capabilities work as one system—reducing handoffs while protecting quality and program knowledge.

Discovery

Target insight, molecular design, and early analytical strategy establish a stronger development starting point.

Development

Process, formulation, quality, and regulatory teams move programs toward clinical readiness.

Manufacturing

Integrated API and finished-dose facilities support clinical and commercial supply under global GMP systems.

Commercialization

Registration and supply capabilities help connect differentiated therapies with international markets.

Partner With Hybio

Build the next therapeutic platform together.

Start a partnership inquiry to discuss APIs, finished dosage forms, or an integrated CRDMO program.

Contact Hybio Request partnership